Advancing your best candidate for regulatory submissions requires a careful assessment of efficacy and toxicity prior to entering human trials. This eBook provides a high-level overview for the preclinical component of your drug development program.

Click here to download a readable, PDF version of this eBook: https://www.altasciences.com/sites/default/files/2022-02/Nonclinical_Safety_Testing_Guide.pdf

Contents of this audiobook:

- Planning Your Pivotal Toxicology Studies

- Small Molecules vs. Biologics

- Species Selection

- Program Study Outlines

- Timing

- SEND Compliance

- Selecting the Right CRO for You

About Altasciences:

Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.